Skip Nav Destination
Article navigation
editorial|
November 07 2023
Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance
Shuko Harada, MD;
Shuko Harada, MD
From the Department of Pathology, The University of Alabama, Birmingham
Search for other works by this author on:
Alexander C. Mackinnon, MD, PhD
From the Department of Pathology, The University of Alabama, Birmingham
Corresponding author: Alexander C. Mackinnon, MD, PhD, Department of Pathology, The University of Alabama at Birmingham, WP 210D, 619 19th St South, Birmingham, AL 35249 (email: amackinnon@uabmc.edu).
Search for other works by this author on:
Arch Pathol Lab Med (2023)
Article history
Accepted:
October 13 2023
Citation
Shuko Harada, Alexander C. Mackinnon; Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance. Arch Pathol Lab Med 2023; doi: https://doi.org/10.5858/arpa.2023-0477-ED
Download citation file:
Sponsored Video
83
Views
Citing articles via
Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists
Matthew G. Hanna, MD, Niels H. Olson, MD, Mark Zarella, PhD, Rajesh C. Dash, MD, Markus D. Herrmann, MD, PhD, Larissa V. Furtado, MD, Michelle N. Stram, MD, Patricia M. Raciti, MD, Lewis Hassell, MD, Alex Mays, MD, Liron Pantanowitz, MD, PhD, MHA, Joseph S. Sirintrapun, MD, Savitri Krishnamurthy, MD, Anil Parwani, MD, PhD, MBA, Giovanni Lujan, MD, Andrew Evans, MD, Eric F. Glassy, MD, Marilyn M. Bui, MD, PhD, Rajendra Singh, MD, Rhona J. Souers, MS, Monica E. de Baca, MD, Jansen N. Seheult, MD
International Council for Standardization in Haematology Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies
Robert C. Gosselin, CLS, Gary W. Moore, BSc, DBMS, Geoffrey W. Kershaw, FAIMS, Silmara Montalvão, PhD, Dorothy M. Adcock, MD
Real-World Evidence of Intra-institutional Performance Variation in Indefinite Diagnosis of Pleural Effusion Cytology
Kuang-Hua Chen, MD, Chien-Yi Kuo, MS, Tai-Di Chen, MD
Recent Advances in Genitourinary Tumors Updates From the 5th Edition of the World Health Organization Blue Book Series
Nicole Riddle, MD, MSHI, Vinita Parkash, MBBS, MPH, Charles C. Guo, MD, Steven S. Shen, MD, Sudhir Perincheri, PhD, MBBS, Angela Sanguino Ramirez, MD, MPH, Aaron Auerbach, MD, MPH, Deborah Belchis, MD, Peter Humphrey, MD, PhD
Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy
Daniel H. Russell, MD, Jonathan I. Epstein, MD, Oleksandr N. Kryvenko, MD, Matthew Schlumbrecht, MD, MPH, Merce Jorda, MD, PhD, MBA, Andre Pinto, MD
Clinicopathologic Features of Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) Breast Cancers
Diane Wilcock, MS, Deepika Sirohi, MD, Daniel Albertson, MD, Allison S. Cleary, MD, PhD, Joshua F. Coleman, MD, Jolanta Jedrzkiewicz, MD, Jonathan Mahlow, MD, Ana L. Ruano, MD, H. Evin Gulbahce, MD, MSCI
Evaluation of the Accuracy of a Polymerase Chain Reaction–Based Assay for Polymerase Epsilon Mutation Detection in Endometrial Carcinoma
Tingting Chen, MD, Yang Li, MD, Xiao Li, MD, Yanyun Zhang, BMe, Weiguo Lv, MD, Xing Xie, MD, Xiaofei Zhang, MD, Xinyu Wang, MD
Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance
Shuko Harada, MD, Alexander C. Mackinnon, MD, PhD